Transporter-14 Mission: SpaceX To Launch Capsules Of DNA, Human Remains Into Space

SpaceX is set to launch the Transporter-14 rideshare mission on a Falcon 9 rocket on Monday (June 23), carrying capsules containing DNA samples and cremated remains from people around the world, Space.com reported.
The samples will be onboard the Perseverance Flight, which is a project by Celestis, a Houston-based company, that offers a unique way to honour loved ones. The Perseverance Flight will carry more than 150 capsules with samples.
The company said that after reaching space, the capsules will return to Earth aboard their recovery vehicle. The memorial capsules will land safely in the Pacific Ocean, where they will be recovered and returned to the family as a "lasting tribute" to their loved one's journey among the stars.
The flight will travel at 17,000 miles per hour and achieve Low Earth Orbit after its launch from the Vandenberg Space Force Base in California. It will complete two to three full orbits around Earth before gently re-entering the atmosphere.
The development highlights the trend of space burial, which has happened in the past. Gene Roddenberry, creator of Star Trek, was the first person to have his remains buried in space in 1992. Eugene Merle Shoemaker, a renowned astronaut, was the first person to have his remains buried on the Moon. Timothy Leary, a psychologist and philosopher, also had his remains launched into space.
In an X post, SpaceX updated that the launch date was changed from Sunday to Monday due to unfavourable weather.
Due to unfavorable weather, now targeting Monday, June 23 for launch of the Transporter-14 mission from California → https://t.co/dZHlwDDeMS
— SpaceX (@SpaceX) June 22, 2025
Celestis announced that it has entered into a new launch service in collaboration with The Exploration Company (TEC) - a European spacecraft manufacturer.
"Celestis is pleased to offer a new type of Earth Rise mission, thanks to The Exploration Company," Charles Chafer, the company's co-founder and CEO, said in a statement. "Our participants' capsules will orbit the Earth and return via the Mission Possible capsule, creating a spectacular liftoff and recovery experience."
What is space burial, and what are the common methods to do it?
The space burial is a unique way to honour the loved ones by launching cremated remains into space.
Earth Orbit: Remains are launched into orbit around the Earth, where they stay for some time before burning up upon re-entry.
Moon Burial: Remains are taken to the lunar surface, providing a lasting tribute.
Deep Space: Remains are launched into deep space, travelling beyond the solar system.
Suborbital Flights: Short flights that cross the boundary of space without reaching orbital velocity, often returning to Earth.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Time of India

an hour ago

• Time of India

Amazon launches 27 Kuiper satellites, to compete with Elon Musk's Starlink

Amazon has launched another 27 satellites for its Project Kuiper, intensifying competition with SpaceX's Starlink in the satellite internet market. This second successful launch brings Amazon's total to 54 satellites in orbit, marking progress toward its goal of providing global internet coverage with a planned constellation of 3,236 satellites. Amazon has launched 27 more satellites under its Project Kuiper on Monday (June 23), taking another step toward building a large network of internet satellites in low Earth orbit. The launch puts Amazon in closer competition with Elon Musk-owned SpaceX's Starlink, which currently leads the satellite internet market. The satellites were launched aboard a United Launch Alliance (ULA) Atlas V rocket from Cape Canaveral Space Force Station in Florida at 6:54 a.m. ET (4:24pm IST). 'We have ignition and lift off of United Launch Alliance Atlas V rocket carrying satellites for Amazon's Project Kuiper internet constellation,' said ULA engineer Ben Chilton during a livestream of the launch. Amazon's second successful Kuiper launch This is Amazon's second successful Kuiper launch. The mission had been delayed twice due to bad weather and a technical issue with the rocket booster. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Trade Bitcoin & Ethereum – No Wallet Needed! IC Markets Start Now Undo The first batch of 27 satellites was sent into orbit in April this year. The company now has a total of 54 Kuiper satellites in space. These launches mark the beginning of Amazon's plan to build a network of 3,236 satellites to provide global internet coverage. Amazon must deploy at least half of its planned satellites — 1,618 — by July 2026 to meet a deadline set by the U.S. Federal Communications Commission (FCC). To achieve this goal, Amazon has booked more than 80 satellite launches with various providers, including SpaceX, its main competitor. Starlink, operated by Elon Musk's SpaceX, already has about 8,000 satellites in orbit and offers satellite internet service globally. Project Kuiper was first announced in 2019 as Amazon's move into the growing satellite internet market. The company says the service will help expand internet access in remote and underserved areas once it becomes fully operational. JOB SCAM ALERT! Don't Let Fake Recruiters Steal Your Money AI Masterclass for Students. Upskill Young Ones Today!– Join Now

NDTV

3 hours ago

• NDTV

SpaceX Launches Dog's Ashes To Space On Memorial Flight

A dog's ashes were among the remains sent into space this weekend as part of a memorial mission honouring loved ones by carrying them beyond Earth's atmosphere. Franz, a beloved family Labrador, was among 166 small capsules launched aboard the inaugural Perseverance SpaceX Flight by Texas-based Celestis Inc. The mission lifted off Sunday around 5:30 pm from Vandenberg Space Force Base in Santa Barbara, California. Franz died aged 13 in October 2020. "He was the best dog, just so soft and nice and loved hugs," said the dog's owner Harvin Moore. The pet was more like a sibling to Mr Moore's children, Elizabeth and Quinn. "Now we can't wait to watch our good boy go galactic," he told The NY Post ahead of the launch. The flight lasted about three hours, during which the capsules orbited Earth twice. The rocket then re-entered the atmosphere and splashed down in the Pacific Ocean somewhere between Alaska and Hawaii. A recovery ship, stationed at sea ahead of time, tracked and retrieved the capsules before sending them to Germany for processing. Within two months, the remains will be returned to their families. The cost to send each capsule into space was $3,500 (over Rs 3 lakh). For Franz's owner, the expense was "a lot more" than the dog's value, but entirely worth it for his family of space enthusiasts. Mr Moore said, "The emotional power of being with a group of people who are celebrating the life of a loved one in this way ... it's amazing. It's nothing we'll ever forget. It's just pure joy." Houston-based Celestis has a long history of sending DNA and cremated remains of people, pets, and celebrities into space using rockets like United Launch Alliance's Vulcan Centaur. Their missions have carried iconic figures such as "Star Trek" legends Nichelle Nichols, DeForest Kelley, Gene Roddenberry and his wife Majel Barrett Roddenberry, and James "Scotty" Doohan. They also flew Douglas Trumbull, a visual effects pioneer behind 2001: A Space Odyssey and Close Encounters of the Third Kind, along with symbolic remains of four former US presidents, George Washington, Dwight D Eisenhower, John F Kennedy, and Ronald Reagan, on last year's deep-space Enterprise Flight. Each capsule, crafted from titanium or aluminium and measuring roughly a quarter to half an inch, contained either DNA or cremated remains. These precious capsules orbited Earth twice aboard a 23-foot-tall SpaceX Falcon 9 rocket, travelling at a speed of almost 28,000 kmph in low Earth orbit. Charles Chafer, Celestis CEO and co-founder said Saturday, "Many people whose ashes and DNA are flying are people that always wanted to go to space in their lifetime but were never able to do that. It also helps families move from feelings of grief to joy." Also aboard the Perseverance Flight were the ashes of Wesley Dreyer, an aerospace engineer involved in investigating the 1986 Space Shuttle Challenger disaster, as well as the DNA of a living three-year-old boy in Germany.

Business Standard

3 hours ago

• Business Standard

Eli Lilly's weekly insulin efsitora shows positive results in Phase 3

US-based pharmaceutical company Eli Lilly on Monday announced findings from the Phase 3 clinical trials for its once-weekly investigational insulin drug, efsitora alfa (efsitora), indicating positive safety and efficacy results for A1C reduction compared to daily basal insulin. While basal insulin is a long-acting insulin administered once or twice a day, efsitora is designed for once-weekly subcutaneous injection. The company also shared detailed results from the Phase 3 QWINT-1, QWINT-3 and QWINT-4 trials. The QWINT-1 trial evaluated adults initiating insulin therapy, while QWINT-3 assessed individuals previously using daily basal insulin. QWINT-4 included participants using both basal and mealtime insulin. 'In each study, efsitora met the primary endpoint of non-inferior A1C reduction compared to daily basal insulin,' the company stated. According to Lilly, in QWINT-1, efsitora reduced A1C by 1.31 per cent compared to 1.27 per cent for insulin glargine at week 52 for the efficacy estimand. In QWINT-3, the drug reduced A1C by 0.86 per cent compared to 0.75 per cent for insulin degludec at week 26. 'In QWINT-4, efsitora reduced A1C by 1.07 per cent, matching insulin glargine's reduction of 1.07 per cent at week 26 for the efficacy estimand,' Lilly added. The Phase 3 global clinical development programme for the diabetes drug began in 2022 and included over 3,000 participants with type 2 diabetes across four global registration studies. Commenting on the results, Jeff Emmick, senior vice president of product development at Lilly, said that the once-weekly insulin therapy may offer a significant advancement for people with type 2 diabetes who need insulin, by eliminating over 300 injections a year. The company added that the drug also has the potential to provide more stable glucose levels—reducing glucose variability—throughout the week. Eli Lilly now plans to submit the drug to global regulatory agencies for the treatment of type 2 diabetes in adults by the end of 2026.